RxAdvance Corp Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- RxAdvance Corp's estimated annual revenue is currently $49.7M per year.
- RxAdvance Corp received $Undisclosed in venture funding in September 2016.
- RxAdvance Corp's estimated revenue per employee is $220,000
- RxAdvance Corp has 226 Employees.
- RxAdvance Corp grew their employee count by 5% last year.
- RxAdvance Corp currently has 14 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Pricing|
|Plymouth Rock A...||$342.5M||1557||N/A||N/A||N/A|
|Cabot Risk Stra...||$16.7M||76||6%||N/A||N/A|
|McSweeney & Ric...||$11M||50||N/A||N/A||N/A|
What Is RxAdvance Corp?
RxAdvance is a national full-service pharmacy benefit manager (PBM) leveraging Collaborative PBM Cloud to manage standard and specialty drug benefits with unmatched regulatory compliance and transparency. In addition, RxAdvance offers a global pharmacy risk partnership model standing shoulder-to-shoulder with plan sponsors. RxAdvance delivers integrated PBM services that reduce overall pharmacy costs and drug-impacted medical costs while improving patients quality of life. With Collaborative PBM Cloud, we administer comprehensive PBM services with operating costs 40% lower than the costs of any other PBM today, which leads to lower administrative fees, reduced drug unit costs, and increased rebate income to plan sponsors. With Intelligent DUR360 Gateway, we promote optimal utilization of drug benefits and reduce overall medical spend. By providing intelligence at the Point of Care and Point of Sale, and establishing a robust platform for member and plan sponsor engagement, we are setting the new standard in PBM service excellence. RxAdvance has created an innovative PBM paradigm that offers Pharmacy cost savings Optimal utilization of drug benefits by leveraging the Intelligent DUR360 Gateway Operational efficiency leading to lower administrative fees Promote untapped generics Control FWA Transform specialty management from a Buy & Bill model to a Value-Based & Outcome-Driven model Drug-impacted medical cost reduction and improved quality of life for patients Medication adherence management (MAM) Coverage gap prediction and prescription planning (CGP3) Reduced adverse drug events Integrated MTM with physician-led CMR Unmatched system-driven regulatory compliance minimizing personnel involvement Care stakeholder collaboration enhances communication between prescribers, pharmacists, patients, and plan sponsors Complete operational visibility and transparency to plan sponsors Unprecedented user configurabilitykeywords:Finance,Healthcare,Insurance,Pharmaceuticals
Number of Employees
Employee Growth %
|Anna Smith||Accountant & Manager, Benefits||Email Available|
|Ravi Ika||President & Ceo||Email Available|
|Prakash Tallabattula||CTO||Email Available|
|Anand Tati||Chief Strategy Officer & EVP Business Development||Email Available|
|Steven Sager||SVP/Legal Counsel|
|John Jacobsen||Chief Financial Officer|
|Ram Mohan Inavilli||Manager (deployments & Automation)|
|Sivaram Vasireddi||Evp Technology||Email Available|
|Aman Khanna||Medical Director||Email Available|
|Mark Owen||Chief Strategy Officer||Email Available|
RxAdvance Corp News
Centene says the rollout of its new relationship with the pharmacy benefit manager RxAdvance is proceeding as planned as the health insurer ...
Tpg-Axon Management Lp increased its stake in Centene Corp Del ... IN HIS CURRENT ROLE AS CEO OF RXADVANCE (ADDS DROPPED ...
Somerset Trust Company increased its stake in Centene Corp Del Com ... 15/03/2018 – Ex-Apple chief says Centene, RxAdvance partnership ...
RxAdvance Corp Funding
|2014-03-04||$Undisclosed||A1||WellMed Medical Management, Inc||Article|
RxAdvance Corp Executive Hires
|2014-09-19||Terry A. Ramey||EVP Business Development/Client Engagement.||Article|
|2016-11-16||John Sculley||Chairman/Chief Marketing Officer||Article|